Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Leopold Hentschel"'
Autor:
Leopold Hentschel, André Wellesen, Luisa Christin Krause, Maria von Havranek, Michael Kramer, Beate Hornemann, Martin Bornhäuser, Ulrich Schuler, Katharina Schütte
Publikováno v:
BMC Palliative Care, Vol 21, Iss 1, Pp 1-7 (2022)
Abstract Background Although the majority of German patients in a palliative state prefer to die at home, the actual place of death is most often a hospital. Unplanned hospital readmissions (UHA) not only contradict most patients’ preferences but a
Externí odkaz:
https://doaj.org/article/0db6c5286d244cf6a14706809dee4472
Autor:
Markus K. Schuler, Uwe Pelzer, Beate Hornemann, Martin Bornhäuser, Jens Marcus Chemnitz, Torsten Kessler, Leopold Hentschel, Stephan Richter, Viktor Grünwald, Karin Arndt, Andrea Schilling, Bernd Kasper, Janet Freitag, Annegret Kunitz, Ulrich Schuler, Hans-Georg Kopp
Publikováno v:
BMJ Open, Vol 10, Iss 8 (2020)
BMJ Open
BMJ Open
ObjectivesThe choice of drug treatment in advanced soft tissue sarcoma (STS) continues to be a challenge regarding efficacy, quality of life (QoL) and toxicity. Unlike other cancer types, where integrating patient-reported outcomes (PRO) has proven t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8da197652718cf5180c7db86b68f3a36
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85090172860
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85090172860
Publikováno v:
BMJ Open
Introduction Even with evolving and expanding therapeutical options for the treatment of advanced sarcomas over recent years, the balance between efficacy and toxicity still remains a major concern. Moreover, the symptom burden in patients with sarco
Autor:
Antje West, Hans-Georg Kopp, Daniel Pink, Leopold Hentschel, Felicitas Lenz, Markus K. Schuler, Christoph Busemann, Sebastian Gerdes, Stephan Richter, Gerhard Ehninger, Peter Reichardt
Publikováno v:
BMC Cancer
Background Anthracyclines, as the most effective therapy, are the cornerstone of advanced stage sarcoma treatment. However, anthracyclines can also contribute to myocardial dysfunction and congestive heart failure, ultimately limiting the therapeutic